邦睿生技-創 (6955)
邦睿生技-創 is a TWSE-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$30.02M, up 14.5% from a year earlier. EPS over the last four quarters totals NT$4.07.
Company profile
Data as of 2026-10-18
- Market
- TWSE-listed
- Industry
- Biotech & Medical Care
- Listed
- 2024-12-06
- Founded
- 2016-01-12
- Paid-in capital
- NT$303.81M
- Common shares issued
- 30,380,960
- Legal name
- 邦睿生技股份有限公司
- Website
- https://www.bonraybio.com
Monthly revenue
Data as of 2026-10-17
| Month | Revenue | MoM | YoY |
|---|---|---|---|
| 2026-09 | NT$30.02M | -2.3% | +14.5% |
| 2026-08 | NT$30.72M | +16.5% | +21.4% |
Year to date: +17.7% vs. last year (Jan–Sep 2026)
Earnings per share (EPS)
Data as of 2026-06-30
| Quarter | EPS (NT$) |
|---|---|
| 2026 Q2 | 1.14 |
| 2026 Q1 | 0.97 |
| 2025 Q4 | 1.20 |
| 2025 Q3 | 0.76 |
| 2025 Q2 | 1.05 |
| 2025 Q1 | 1.12 |
| 2024 Q4 | 1.17 |
| 2024 Q3 | 0.72 |
Last four quarters: NT$4.07
Dividends
Data as of 2026-10-18
| Period | Cash (NT$) | Stock (NT$) | Ex-dividend | Ex-rights | Paid |
|---|---|---|---|---|---|
| 2025 年度 | 1.50 | 2.25 | — | — | — |
Shareholder structure
Data as of 2026-10-16
| Holding range | Holders | Share of total |
|---|---|---|
| 1–999 shares | 198 | 0.1% |
| 1,000–5,000 shares | 146 | 1.1% |
| 5,001–10,000 shares | 38 | 0.9% |
| 10,001–15,000 shares | 28 | 1.2% |
| 15,001–20,000 shares | 10 | 0.6% |
| 20,001–30,000 shares | 18 | 1.4% |
| 30,001–40,000 shares | 9 | 1.0% |
| 40,001–50,000 shares | 6 | 0.9% |
| 50,001–100,000 shares | 18 | 4.2% |
| 100,001–200,000 shares | 11 | 4.9% |
| 200,001–400,000 shares | 22 | 20.4% |
| 400,001–600,000 shares | 5 | 8.7% |
| 600,001–800,000 shares | 1 | 2.3% |
| 800,001–1,000,000 shares | 1 | 2.7% |
| 1,000,001+ shares | 6 | 49.6% |
TDCC data for 2026-10-16: 6 holders own more than 1,000 lots (49.6% of shares), and 198 hold less than one lot (0.1%).
Institutional net buying (last 20 trading days)
Data as of 2026-10-19
| Date | Foreign | Trust | Dealers | Total |
|---|---|---|---|---|
| 2026-10-19 | 0 | 0 | 3 | 3 |
| 2026-10-16 | 0 | 0 | -3 | -3 |
| 2026-10-15 | 4 | 0 | 2 | 6 |
| 2026-10-14 | 0 | 0 | 0 | 0 |
| 2026-10-13 | 0 | 0 | 0 | 0 |
| 2026-10-12 | 0 | 0 | 0 | 0 |
| 2026-10-08 | 1 | 0 | 0 | 1 |
| 2026-10-07 | -1 | 0 | 0 | -1 |
| 2026-10-06 | 0 | 0 | -2 | -2 |
| 2026-10-05 | 2 | 0 | 3 | 5 |
| 2026-10-02 | -3 | 0 | 4 | 1 |
| 2026-10-01 | 0 | 0 | 5 | 5 |
| 2026-09-30 | 1 | 0 | -3 | -2 |
| 2026-09-29 | 0 | 0 | 0 | 0 |
| 2026-09-24 | 1 | 0 | 0 | 1 |
| 2026-09-23 | 2 | 0 | 0 | 2 |
| 2026-09-22 | 0 | 0 | 0 | 0 |
| 2026-09-21 | 0 | 0 | 1 | 1 |
| 2026-09-18 | 1 | 0 | 0 | 1 |
| 2026-09-17 | -1 | 0 | 3 | 2 |
Unit: lots (1,000 shares). Over the last 20 trading days, institutions were net buyers of 20 lots.
Price (official close)
Data as of 2026-10-19
Last close NT$92.20 (2026-10-19); 52-week range NT$89.60–177.00.
Sources
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Market Observation Post System (MOPS)
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Depository & Clearing Corporation public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
Charts, drawing tools, and the P/E calculator are in the app, free to use.